Table 5 Estimated effective doses of 123 I-CMICE-013 for male and female humans
Organ | Male | Female | ||
|---|---|---|---|---|
Equivalent dose to target organ (mSv/MBq) | Weighted equivalent dose (mSv/MBq) | Equivalent dose to target organ (mSv/MBq) | Weighted equivalent dose (mSv/MBq) | |
Adrenals | 5.35E-03 | 2.68E-05 | 6.72E-03 | 3.36E-05 |
Brain | 3.84E-03 | 1.92E-05 | 4.86E-03 | 2.43E-05 |
Breasts | 3.40E-03 | 1.70E-04 | 4.36E-03 | 2.18E-04 |
LLI | 6.63E-03 | 7.96E-04 | 7.96E-03 | 9.55E-04 |
SI | 6.82E-03 | 3.41E-05 | 7.80E-03 | 3.90E-05 |
Stomach | 1.36E-02 | 1.63E-03 | 1.64E-02 | 1.97E-03 |
ULI | 6.92E-03 | 3.46E-05 | 8.44E-03 | 4.22E-05 |
Kidneys | 4.87E-03 | 2.44E-05 | 6.08E-03 | 3.04E-05 |
Liver | 5.76E-03 | 2.88E-04 | 7.48E-03 | 3.74E-04 |
Lungs | 4.81E-03 | 5.77E-04 | 6.33E-03 | 7.60E-04 |
Muscle | 4.17E-03 | 2.09E-05 | 5.16E-03 | 2.58E-05 |
Pancreas | 6.49E-03 | 3.25E-05 | 8.03E-03 | 4.02E-05 |
Red marrow | 3.91E-03 | 4.69E-04 | 4.73E-03 | 5.68E-04 |
Osteogenic cells | 1.37E-02 | 1.37E-04 | 1.76E-02 | 1.76E-04 |
Skin | 2.89E-03 | 2.89E-05 | 3.53E-03 | 3.53E-05 |
Spleen | 5.29E-03 | 2.65E-05 | 6.58E-03 | 3.29E-05 |
Testes (m)/Ovary (f) | 3.92E-03 | 7.84E-04 | 6.77E-03 | 1.35E-03 |
Thymus | 4.92E-03 | 2.46E-05 | 6.19E-03 | 3.10E-05 |
Thyroid | 1.24E-02 | 6.20E-04 | 1.44E-02 | 7.20E-04 |
Bladder | 6.56E-03 | 3.28E-04 | 8.28E-03 | 4.14E-04 |
Uterus | 5.58E-03 | 2.79E-05 | 6.63E-03 | 3.32E-05 |
ED ICRP 60 | 6.99E-03 | |||
ED ICRP 103 | 7.15E-03 | |||